Rare Disease Biotech Setara Starts Out With $90M and a Lead Drug in the Clinic
Setara Biosciences’ lead program is a possible remedy for the uncommon neuromuscular dysfunction Charcot-Marie-Tooth illness sort 2C and the prevalent ...
Setara Biosciences’ lead program is a possible remedy for the uncommon neuromuscular dysfunction Charcot-Marie-Tooth illness sort 2C and the prevalent ...
Artiva Biotherapeutics attributed one of many fatalities to a drug used to arrange sufferers for cell remedy and to not ...
Corxel Prescribed drugs is catching as much as others with oral GLP-1 weight problems medication, however the biotech claims its ...
Prime of the morning to you. Blue skies, cool breezes, and loads of chirping birds are enveloping the comfortable Pharmalot ...
Iambic Therapeutics, an AI-enabled biotech firm, will apply the IPO proceeds towards medical improvement of its pipeline of internally found ...
One takeaway from this 12 months’s surge of biotech IPO exercise is that traders need to see at the least ...
REDWOOD CITY, Calif. — By all rights, Felix Wong and his firm ought to be in Massachusetts. Wong, 33, was ...
Scribe Therapeutics’ IPO will help a pipeline led by a genetic drugs that represses expression of its goal gene with ...
Hemab Therapeutics and Seaport Therapeutics are the latest biotech firms to hitch the general public markets, every with an upsized ...
Good morning, everybody, and welcome to a different working week. We hope the weekend respite was stress-free and invigorating as ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.